Georgios Kareliotis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Georgios Kareliotis has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Mersini Makropoulou
Physics Department, Laser Development and Applications Team, National Technical University of Athens, Zografou Campus, Athens, Greece
5 shared publicationsIoannis Datseris
Nuclear Medicine -PET/CT Department Laser Development and Applications Team General Hospital of Athens -Evaggelismos‖ Ypsilantou 45-47 10676 Athens Greece
2 shared publicationsMaria Papachristou
Nuclear Medicine -PET/CT Department Laser Development and Applications Team General Hospital of Athens -Evaggelismos‖ Ypsilantou 45-47 10676 Athens Greece
2 shared publications- Mersini Makropoulou
National Technical University of Athens
2 shared publications A.A. Serafetinides
Physics Department, Laboratory of "Optoelectronics and Laser Applications", National Technical University of Athens, Zografou Campus, 15780 Athens, Greece
1 shared publicationAlexandros A. Serafetinides
Department of Physics, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 27 February 2023
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 4 (1) , 86-105
Novel Biophotonic Techniques for Phototherapy Enhancement: Cerenkov Radiation as a Bridge between Ionizing and Non-Ionizing Radiation Treatment
In oncology, tremendous research has been conducted on the use of alternative minimally invasive techniques for cancer treatment and diagnosis. The use of biophotonic techniques as a standalone treatment or together with conventional imaging techniques has gained interest among researchers in recent years, while biophotonic therapies such as photothermal and photodynamic therapies tend to bring the use of non-ionizing radiation in therapy back into the spotlight due to the progressive development of optical instrumentation, enhancement agents, molecular probes, light sources and nanocarriers. Thus, the coupling of non-ionizing with ionizing radiation (IR) and the combination of nanomedicine with nuclear medicine procedures are considered to be revolutionary strategies to optimize the therapeutic efficacy of biophotonic modalities and to develop theranostic applications for the better diagnosis and treatment of cancer. Recently, the low-intensity Cerenkov light emitted by tissues as a byproduct of the IR–biostructure interaction has been suggested as an effective internal light source that can trigger phototherapy and guide radiotherapy dosimetry using Cerenkov imaging. This review also provides an overview of in vitro and in vivo studies regarding the use of Cerenkov radiation produced by X-rays or radionucleotides and combined with nanoparticles as a hybrid method to induce enhanced photothermal and photodynamic therapies.
- 27 February 2023
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 4 (1) , 86-105
Open AccessNovel Biophotonic Techniques for Phototherapy Enhancement: Cerenkov Radiation as a Bridge between Ionizing and Non-Ionizing Radiation Treatment
In oncology, tremendous research has been conducted on the use of alternative minimally invasive techniques for cancer treatment and diagnosis. The use of biophotonic techniques as a standalone treatment or together with conventional imaging techniques has gained interest among researchers in recent years, while biophotonic therapies such as photothermal and photodynamic therapies tend to bring the use of non-ionizing radiation in therapy back into the spotlight due to the progressive development of optical instrumentation, enhancement agents, molecular probes, light sources and nanocarriers. Thus, the coupling of non-ionizing with ionizing radiation (IR) and the combination of nanomedicine with nuclear medicine procedures are considered to be revolutionary strategies to optimize the therapeutic efficacy of biophotonic modalities and to develop theranostic applications for the better diagnosis and treatment of cancer. Recently, the low-intensity Cerenkov light emitted by tissues as a byproduct of the IR–biostructure interaction has been suggested as an effective internal light source that can trigger phototherapy and guide radiotherapy dosimetry using Cerenkov imaging. This review also provides an overview of in vitro and in vivo studies regarding the use of Cerenkov radiation produced by X-rays or radionucleotides and combined with nanoparticles as a hybrid method to induce enhanced photothermal and photodynamic therapies.
- Open Access
- 28 February 2022
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 3 (1) , 39-54
In Silico, Combined Plasmonic Photothermal and Photodynamic Therapy in Mice
Plasmonic photothermal and photodynamic therapy (PPTT and PDT, respectively) are two cancer treatments that have the potential to be combined in a synergistic scheme. The aim of this study is to optimize the PPTT treatment part, in order to account for the PDT lack of coverage in the hypoxic tumor volume and in cancer areas laying in deep sites. For the needs of this study, a mouse was modeled, subjected to PDT and its necrotic area was estimated by using the MATLAB software. The same procedure was repeated for PPTT, using COMSOL Multiphysics. PPTT treatment parameters, namely laser power and irradiation time, were optimized in order to achieve the optimum therapeutic effect of the combined scheme. The PDT alone resulted in 54.8% tumor necrosis, covering the upper cancer layers. When the PPTT was also applied, the total necrosis percentage raised up to 99.3%, while all of the surrounding studied organs (skin, heart, lungs and trachea, ribs, liver and spleen) were spared. The optimized values of the PPTT parameters were 550 mW of laser power and 70 s of irradiation time. Hence, the PPTT–PDT combination shows great potential in achieving high levels of tumor necrosis while sparing the healthy tissues.
- 28 February 2022
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 3 (1) , 39-54
Open AccessIn Silico, Combined Plasmonic Photothermal and Photodynamic Therapy in Mice
Plasmonic photothermal and photodynamic therapy (PPTT and PDT, respectively) are two cancer treatments that have the potential to be combined in a synergistic scheme. The aim of this study is to optimize the PPTT treatment part, in order to account for the PDT lack of coverage in the hypoxic tumor volume and in cancer areas laying in deep sites. For the needs of this study, a mouse was modeled, subjected to PDT and its necrotic area was estimated by using the MATLAB software. The same procedure was repeated for PPTT, using COMSOL Multiphysics. PPTT treatment parameters, namely laser power and irradiation time, were optimized in order to achieve the optimum therapeutic effect of the combined scheme. The PDT alone resulted in 54.8% tumor necrosis, covering the upper cancer layers. When the PPTT was also applied, the total necrosis percentage raised up to 99.3%, while all of the surrounding studied organs (skin, heart, lungs and trachea, ribs, liver and spleen) were spared. The optimized values of the PPTT parameters were 550 mW of laser power and 70 s of irradiation time. Hence, the PPTT–PDT combination shows great potential in achieving high levels of tumor necrosis while sparing the healthy tissues.
- 1 January 2021
- Published by Begell House Inc. Publishers in Journal of Long-Term Effects of Medical Implants
- Vol. 31 (2) , 55-69
The Facts and Myths for the Use of Lasers in Orthopedic Surgery
For the past three decades, laser use has been investigated, mainly on implant applications, as well as hard and soft tissue processing on Orthopaedics. However, despite significant technological advances and achievements in Biophotonics, lasers have yet to emerge as a successful tool for hard-tissue manipulation (e.g. osseous tissue). Indeed, a careful search in relevant literature reveals a limited number of laser-based clinical applications in Orthopaedics, except for the Low-Level Laser Therapy (LLLT) applications. In this review article, we give a brief overview of the biophysical mechanisms of bone tissue and biocompatible implants laser surgery and, in parallel, we summarize some specific pre-clinical and clinical laser applications in Orthopaedics. Taking into consideration the complexity of laser-based applications in inhomogeneous musculoskeletal biostructures and/or implants, it is justified to state that applying laser radiation is still an open field of multidisciplinary research before performing interventions in clinical praxis. The evidence from this study indicates the need for more experimental and theoretical studies regarding light transport on soft and hard tissues, in order to further enhance safe and efficient laser applications in Orthopaedics. This undoubtedly implies the need for developing modern light delivery devices for laser surgery, by means of implementing robotic guidance, specialized for medical procedures on various anatomic structures. The aforementioned studies could eventually revolutionize the clinical applications of laser technology in Orthopaedics.
- 1 January 2021
- Published by Begell House Inc. Publishers in Journal of Long-Term Effects of Medical Implants
- Vol. 31 (2) , 55-69
The Facts and Myths for the Use of Lasers in Orthopedic Surgery
For the past three decades, laser use has been investigated, mainly on implant applications, as well as hard and soft tissue processing on Orthopaedics. However, despite significant technological advances and achievements in Biophotonics, lasers have yet to emerge as a successful tool for hard-tissue manipulation (e.g. osseous tissue). Indeed, a careful search in relevant literature reveals a limited number of laser-based clinical applications in Orthopaedics, except for the Low-Level Laser Therapy (LLLT) applications. In this review article, we give a brief overview of the biophysical mechanisms of bone tissue and biocompatible implants laser surgery and, in parallel, we summarize some specific pre-clinical and clinical laser applications in Orthopaedics. Taking into consideration the complexity of laser-based applications in inhomogeneous musculoskeletal biostructures and/or implants, it is justified to state that applying laser radiation is still an open field of multidisciplinary research before performing interventions in clinical praxis. The evidence from this study indicates the need for more experimental and theoretical studies regarding light transport on soft and hard tissues, in order to further enhance safe and efficient laser applications in Orthopaedics. This undoubtedly implies the need for developing modern light delivery devices for laser surgery, by means of implementing robotic guidance, specialized for medical procedures on various anatomic structures. The aforementioned studies could eventually revolutionize the clinical applications of laser technology in Orthopaedics.
- Open Access
Photodynamic therapy of 4T1 tumors in NOD-SCID mice
Background: Promising results for mammary carcinoma treatment with photodynamic therapy (PDT) presuppose a careful selection of irradiation light wavelength. Methods: 4T1 tumors implanted in NOD-SCID mice were treated with Metvix-PDT under 625 nm, 660 nm and their combination light, for a fixed radiant exposure. The therapeutic outcome was assessed through Monte Carlo based computational simulations along with a preliminary in vivo study, where fluorescence, size and temperature measurements were conducted. Results: The light source combination protocol presents great potential, since it results in high cytotoxic products levels and reduced treatment times; while the in vivo findings, regarding the harvested tumor mass, also support this hypothesis. The irradiation with 625 nm beam alone presented better results for most of the in vivo measured parameters. The mouse treated with only the 660 nm light source had the highest un-photobleached photosensitizer (PS) signal, the lowest body temperature, the heaviest harvested tumor and the lowest estimated concentration of PDT cytotoxic products. Conclusions: The use of 625 nm irradiation light matches the PS excitation band but is preferable only for treatment of superficial tumors. For deeper laying masses, the simultaneous use of longer wavelengths enhances the therapeutic outcome due to their increased penetration depth.
Open AccessPhotodynamic therapy of 4T1 tumors in NOD-SCID mice
Background: Promising results for mammary carcinoma treatment with photodynamic therapy (PDT) presuppose a careful selection of irradiation light wavelength. Methods: 4T1 tumors implanted in NOD-SCID mice were treated with Metvix-PDT under 625 nm, 660 nm and their combination light, for a fixed radiant exposure. The therapeutic outcome was assessed through Monte Carlo based computational simulations along with a preliminary in vivo study, where fluorescence, size and temperature measurements were conducted. Results: The light source combination protocol presents great potential, since it results in high cytotoxic products levels and reduced treatment times; while the in vivo findings, regarding the harvested tumor mass, also support this hypothesis. The irradiation with 625 nm beam alone presented better results for most of the in vivo measured parameters. The mouse treated with only the 660 nm light source had the highest un-photobleached photosensitizer (PS) signal, the lowest body temperature, the heaviest harvested tumor and the lowest estimated concentration of PDT cytotoxic products. Conclusions: The use of 625 nm irradiation light matches the PS excitation band but is preferable only for treatment of superficial tumors. For deeper laying masses, the simultaneous use of longer wavelengths enhances the therapeutic outcome due to their increased penetration depth.
- 15 July 2020
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 96 (9) , 1087-1103
Combined radiation strategies for novel and enhanced cancer treatment
Purpose: Numerous studies focus on cancer therapy worldwide, and although many advances have been recorded, the complexity of the disease dictates thinking out of the box to confront it. This study reviews some of the currently available ionizing (IR) and non-ionizing radiation (NIR)-based treatment methods and explores their possible combinations that lead to synergistic, multimodal approaches with promising therapeutic outcomes. Conclusion: Traditional techniques, like radiotherapy (RT) show decent results, although they cannot spare 100% the healthy tissues neighboring with the cancer ones. Targeted therapies, such as proton and photodynamic therapy (PT and PDT, respectively) present adequate outcomes, even though each one has its own drawbacks. In order to overcome these limitations, the combination of therapeutic modalities has been proposed and has already been showing promising results. At the same time, the recent advances in nanotechnology in the form of nanoparticles enhance cancer therapy, making multimodal treatments worthy of exploring and studying. The combination of RT and PDT has reached the level of clinical trials and is showing promising results. Moreover, in vitro and in vivo studies of nanoparticles with PDT have also provided beneficial results concerning enhanced radiation treatments. In any case, novel and multimodal approaches have to be adopted in order to achieve personalized, enhanced and effective cancer treatment.
- 15 July 2020
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 96 (9) , 1087-1103
Combined radiation strategies for novel and enhanced cancer treatment
Purpose: Numerous studies focus on cancer therapy worldwide, and although many advances have been recorded, the complexity of the disease dictates thinking out of the box to confront it. This study reviews some of the currently available ionizing (IR) and non-ionizing radiation (NIR)-based treatment methods and explores their possible combinations that lead to synergistic, multimodal approaches with promising therapeutic outcomes. Conclusion: Traditional techniques, like radiotherapy (RT) show decent results, although they cannot spare 100% the healthy tissues neighboring with the cancer ones. Targeted therapies, such as proton and photodynamic therapy (PT and PDT, respectively) present adequate outcomes, even though each one has its own drawbacks. In order to overcome these limitations, the combination of therapeutic modalities has been proposed and has already been showing promising results. At the same time, the recent advances in nanotechnology in the form of nanoparticles enhance cancer therapy, making multimodal treatments worthy of exploring and studying. The combination of RT and PDT has reached the level of clinical trials and is showing promising results. Moreover, in vitro and in vivo studies of nanoparticles with PDT have also provided beneficial results concerning enhanced radiation treatments. In any case, novel and multimodal approaches have to be adopted in order to achieve personalized, enhanced and effective cancer treatment.
- Open Access
- 1 January 2020
- Published by Open Access Text Pvt, Ltd. in New Frontiers in Ophthalmology
- Vol. 6 (2)
Laser-intraocular lenses interaction: Aspects to consider for in situ vision correction
- 1 January 2020
- Published by Open Access Text Pvt, Ltd. in New Frontiers in Ophthalmology
- Vol. 6 (2)
Open AccessLaser-intraocular lenses interaction: Aspects to consider for in situ vision correction
- 1 July 2019
- Published by Elsevier in Physica Medica
- Vol. 63, 7-18
Non-ionizing, laser radiation in Theranostics: The need for dosimetry and the role of Medical Physics
- 1 July 2019
- Published by Elsevier in Physica Medica
- Vol. 63, 7-18
Non-ionizing, laser radiation in Theranostics: The need for dosimetry and the role of Medical Physics
- 1 March 2019
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 192, 40-48
Computational study of necrotic areas in rat liver tissue treated with photodynamic therapy
- 1 March 2019
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 192, 40-48
Computational study of necrotic areas in rat liver tissue treated with photodynamic therapy
- 1 March 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 21, 224-233
Assessment of singlet oxygen dosimetry concepts in photodynamic therapy through computational modeling
- 1 March 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 21, 224-233
Assessment of singlet oxygen dosimetry concepts in photodynamic therapy through computational modeling